Log in

A New Tool Predicting Survival After Radiosurgery Alone for One or Two Cerebral Metastases from Lung Cancer

  • Published:
Lung Aims and scope Submit manuscript

Abstract

Radiosurgery is frequently used for patients with few cerebral metastases. Decisions regarding personalized treatment should include the patient’s survival prognosis. Prognostic tools should be available for estimating the remaining lifetime for each primary tumor and treatment. We designed such a tool for patients receiving radiosurgery alone for cerebral metastases from lung cancer. Ten variables were analyzed in 98 patients. On multivariate analysis, extra-cranial spread was significantly associated with worse survival (p < 0.001). A trend was observed for poorer performance status (p = 0.08) and greater diameter of cerebral lesions (p = 0.07). Points for the tool were derived from 12-month survival rates of these variables and added, resulting in sum scores of 10–16 points. Three groups were built, 10–12, 14–15, and 16 points with 12-month survival rates of 22, 52, and 79 % (p < 0.001). This new tool enables physicians to estimate the survival of lung cancer patients with few cerebral metastases which should impact individualized treatment choices.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Tsao MN, Rades D, Wirth A, Lo SS, Danielson BL, Gaspar LE, Sperduto PW, Vogelbaum MA, Radawski JD, Wang JZ, Gillin MT, Mohideen N, Hahn CA, Chang EL (2012) Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): an American Society for Radiation Oncology evidence-based guideline. Pract Radiat Oncol 2:210–225

    Article  PubMed Central  Google Scholar 

  2. Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, Arbuckle RB, Swint JM, Shiu AS, Maor MH, Meyers CA (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10:1037–1044

    Article  PubMed  Google Scholar 

  3. DeAngelis LM, Delattre JY, Posner JB (1989) Radiation-induced dementia in patients cured of brain metastases. Neurology 39:789–796

    Article  CAS  PubMed  Google Scholar 

  4. Rades D, Hornung D, Blanck O, Martens K, Khoa MT, Trang NT, Hüppe M, Terheyden P, Gliemroth J, Schild SE (2014) Stereotactic radiosurgery for newly diagnosed brain metastases : comparison of three dose levels. Strahlenther Onkol 190:786–791

    Article  PubMed  Google Scholar 

  5. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhardt R (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745–751

    Article  CAS  PubMed  Google Scholar 

  6. Weltman E, Salvajoli JV, Brandt RA, De Morais Hanriot R, Prisco FE, Cruz JC, De Oliveira Borges SR, Wajsbrot DB (2000) Radiosurgery for brain metastases: a score index for predicting prognosis. Int J Radiat Oncol Biol Phys 46:1155–1161

    Article  CAS  PubMed  Google Scholar 

  7. Lorenzoni J, Devriendt D, Massager N, David P, Ruíz S, Vanderlinden B, Van Houtte P, Brotchi J, Levivier M (2004) Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems. Int J Radiat Oncol Biol Phys 60:218–224

    Article  PubMed  Google Scholar 

  8. Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W (2008) A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 70:510–514

    Article  PubMed  Google Scholar 

  9. Rades D, Dunst J, Schild SE (2008) A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases. Strahlenther Onkol 184:251–255

    Article  PubMed  Google Scholar 

  10. Kaplan EL, Meier P (1958) Non parametric estimation from incomplete observations. J Am Stat Assoc 53:457–481

    Article  Google Scholar 

  11. Tam TC, Ho JC, Wong MK, Wong WM, Wang JK, Lam JC, Lui MM, Lam WK, Ip MS, Lam DC (2013) Treatment outcomes in elderly with advanced-stage non-small cell lung cancer. Lung 191:645–654

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Wibmer T, Berghmans T, Kropf-Sanchen C, Lafitte JJ, Rüdiger S, Paesmans M, Blanta I, Scherpereel A, Stoiber KM, Rottbauer W, Sculier JP, Schumann C (2013) Histology as a potential clinical predictor of outcome in advanced non-small-cell lung cancer treated with vinorelbine and mitomycin combination chemotherapy. Lung 191:271–280

    Article  CAS  PubMed  Google Scholar 

  13. Sperduto PW, Chao ST, Sneed PK, Luo X, Suh J, Roberge D, Bhatt A, Jensen AW, Brown PD, Shih H, Kirkpatrick J, Schwer A, Gaspar LE, Fiveash JB, Chiang V, Knisely J, Sperduto CM, Mehta M (2010) Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 77:655–661

    Article  PubMed  Google Scholar 

  14. Rades D, Dziggel L, Segedin B, Oblak I, Nagy V, Marita A, Schild SE, Trang NT, Khoa MT (2013) A new survival score for patients with brain metastases from non-small cell lung cancer. Strahlenther Onkol 189:777–781

    Article  CAS  PubMed  Google Scholar 

  15. Rades D, Dziggel L, Segedin B, Oblak I, Nagy V, Marita A, Schild SE (2013) The first survival score for patients with brain metastases from small cell lung cancer (SCLC). Clin Neurol Neurosurg 115:2029–2032

    Article  PubMed  Google Scholar 

  16. Golden DW, Lamborn KR, McDermott MW, Kunwar S, Wara WM, Nakamura JL, Sneed PK (2008) Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site. J Neurosurg 109(Suppl):77–86

    PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dirk Rades.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rades, D., Huttenlocher, S., Dziggel, L. et al. A New Tool Predicting Survival After Radiosurgery Alone for One or Two Cerebral Metastases from Lung Cancer. Lung 193, 299–302 (2015). https://doi.org/10.1007/s00408-014-9676-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-014-9676-4

Keywords

Navigation